Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018
- Language: English
- 293 Pages
- Published: February 2013
- Region: Global
Aptamers Market - Technology Trend Analysis By Applications - Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis - Global Forecasts to 2018
Aptamers is an emerging market sector, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. This research report categorizes the global aptamers market into geography, applications, and aptamer type. The applications market is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.
Aptamers existed alongside antibodies for two decades, but their market potential was not utilized to even a fraction of the same degree. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.
Though there are just approximately 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups focused on the diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a large number of patents granted and filed for this technology.
In this report the aptamers market is analyzed both in terms of qualitative, i.e. technological and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.
The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production cost compared to antibodies aid the growth of the market. However, the reduced market acceptance compared to the antibodies and increased time consumption for screening using SELEX will hamper the growth of this market, to a certain extent. While aptamer technology has existed for over two decades, the challenges imposed on the development of aptamers for small molecules has resulted in very few novel aptamers that can bind to practical small molecular targets. Nevertheless, there are many opportunities for the innovative application of small molecule binding aptamers in biosensing, drug discovery, diagnostics and therapeutics.
As well as a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.
Furthermore this report assesses the investor climate by tracking the complete investor network and collecting data on funds/grants and investments made in aptamers. Insights on current and future technological investment trends have also been discussed. The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.
- A detailed description of the global technology developments and evolving trends in the aptamers field with key prominence on research innovations, collaborative efforts, and investments for aptamers.
- A close view on the aptamer based drug development for treatment of specific diseases by providing details and status of current aptamer drugs in pipeline.
- An impact analysis of major drivers and restraints influencing the adoption and growth of the aptamers market during the period of 2013to 2018.
- Porters five forces analysis and SWOT analysis.
- Global market forecast for 2013-2018, including demand side analysis and strategic recommendations for technology/product developers.
- Competitive landscape based on the analysis of key patents and research publications.
Scope of the Report
- Drug discovery
- Biomarker discovery
- Research applications
By Aptamer Type
- Nucleic acid aptamers
- Peptide aptamers
- North America
- Asia Pacific
- Rest of the World (RoW) SHOW LESS READ MORE >
1.1 Logical Assumptions In This Study Based On Reliable Sources
1.2 Key Take-Aways
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources
2 Executive Summary
3 Aptamers – Technology Landscape Analysis
3.1 Technology Overview
3.2 History & Milestones Of Aptamers
3.3 Aptamers Vs Antibodies
3.4 Aptamer Types
3.4.1 Nucleic Acid Aptamers
3.4.2 Peptide Aptamers
3.5 Aptamer Synthesis & Modifications
18.104.22.168 Different Targets Of Therapeutic Interest
3.6.4 Drug Discovery
3.6.5 Biomarker Discovery
3.6.6 Research Applications
22.214.171.124 Reagents & Assays
126.96.36.199 Flow Cytometry
188.8.131.52 Mass Spectrometry
184.108.40.206 Western Blotting
3.7 Technology Value Chain Analysis
3.8 Aptamers – Technology Innovations And Products With Applications
4 Aptamers – Market Landscape Analysis
4.1 Aptamers Market Segmentation
4.2 Aptamers Technology - Global Impact
4.3 Market Forecast (2013 - 2018) – Overview
4.4 Global Aptamers Market Revenue Forecast (2013-2018)
4.4.1 Global Aptamers Market Revenue – By Geography
220.127.116.11 North America
18.104.22.168 Asia Pacific
22.214.171.124 Rest Of The World
4.4.2 Global Aptamers Market Share – By Geography
126.96.36.199 North America
188.8.131.52 Asia Pacific
184.108.40.206 Rest Of The World
4.4.3 Global Aptamers Market Revenue – By Application Segments
220.127.116.11 Global Aptamers Market Share – By Segments
18.104.22.168 Therapeutic Aptamers Market – By Region
22.214.171.124 Diagnostics Aptamers Market – By Region
126.96.36.199 Biosensors Aptamers Market – By Region
188.8.131.52 Drug Discovery Aptamers Market – By Region
184.108.40.206 Aptamers Biomarker Discovery Market – By Region
220.127.116.11 Aptamers Research Applications Market – By Region
4.4.4 Global Aptamers Market Revenue – By Aptamer Type
18.104.22.168 Nucleic Acid Aptamer Market – By Region
22.214.171.124 Peptide Aptamer Market – By Region
126.96.36.199 Nucleic Acid And Peptide Aptamers Market Share – By Region
4.5 Market Dynamics
4.5.1 Drivers - Explanation
188.8.131.52 Impact Analysis By Timeline
4.5.2 Restraints – Explanation
184.108.40.206 Impact Analysis By Timeline
4.6 SWOT Analysis
4.7 Porter’s Five Forces Analysis
5 Technology Investment Potential
5.1 Investment Climate Assessment
5.2 Investor Network
5.3 Some Funds And Investments On Aptamers
5.4 Some Funds And Investments From Nih – By Fiscal Year
5.5 Some Funds And Investments From Nih – By Its Associated Institutes/Centers (FY 2008-2013)
5.6 Insights On Current And Future Tech-Investment Trends
6 Aptamers – Technology Adoption And Development Potential
6.1 Geographic Adoption And Development Potential - Overview
6.2 North America
6.5 Row – Selected Countries
6.6 Demand Side Analysis
6.7 Technology Roadmap
7 Aptamers Competitive Landscape
7.1 Competitive Landscape Analysis
7.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2009 – 2013)
7.3 Startups And Spinoff’s Based On Aptamers Technology
7.4 Clinical Trials Of Aptamers – By Different Properties (Anti-Coagulant Aptamers, Anti-Angiogenic Aptamers, Anti-Oncogenic Aptamers, Anti-Diabetic Aptamers)
7.4.1 Apamer Based Drugs In Clinical Trials
8 Intellectual Property And Research Strength Analysis
8.1 Selected Aptamer And Selex Patents
8.2 IP Strength Analysis Of Aptamers
8.3 Proprietary Technologies Based On Aptamers
9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Strategic Recommendations For Technology & Business Investors
9.3 Open Opportunity Invitations In The Field For Business Development
10 Company Profiles (Slide No- 134)
10.1 AM Biotechnologies, Llc
10.2 Aptagen, LIC
10.3 Aptamer Sciences Inc.
10.4 Aptamer Solutions Ltd
10.5 Aptares AG
10.6 Base Pair Biotechnologies
10.7 Integrated Dna Technologies, Inc
10.8 Neoventures Biotechnology Inc.
10.9 NOXXON Pharma AG
10.10 OTC Biotech
10.11 Somalogic, Inc.
10.12 Trilink Biotechnologies, Inc.
10.15 Aptamatrix, Inc.
10.17 Bioapter S.L.
10.18 Cd Genomics
10.19 Lucerna, Inc.
10.20 Ophthotech Corporation
10.21 Regado Biosciences, Inc.
List Of Tables ( 14 Tables)
Table 1 Global Aptamers Market, 2013 - 2018 ($Million)
Table 2 Global Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 3 Global Aptamers Market Revenue, By Application Segment, 2013 - 2018 ($Million)
Table 4 Therapeutic Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 5 Diagnostics Aptamers Market, By Region, 2013 - 2018 ($Million)
Table 6 Biosensor Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 7 Drug Discovery Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 8 Aptamers Biomarker Discovery Market, By Geography, 2013 - 2018 ($Million)
Table 9 Aptamers Research Applications Market, By Geography, 2013 - 2018 ($Million)
Table 10 Global Aptamers Market, By Type, 2013 - 2018 ($Million)
Table 11 Nucleic Acid Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 12 Peptide Aptamers Market, By Geography, 2013 - 2018 ($Million)
Table 13 Funds By Nih & Associated Centers 2008-2013 ($Million)
Table 14 Projects And Funds By Nih & Associated Centers 2008-2013 ($Million)
List Of Figures (29 Figures)
Figure 1 Global Market Of Aptamers 2013 – 2018 ($Million)
Figure 2 Global Market Of Aptamers 2013 – 2018 ($Million)
Figure 3 Global Aptamers Market Revenue, By Geography, 2013 – 2018 ($Million)
Figure 4 Global Aptamers Market Share By Geography, 2013
Figure 5 Global Aptamers Market Share By Geography, 2018
Figure 6 Global Aptamers Technology Market Revenue, By Applications, 2013 – 2018 ($Million)
Figure 7 Global Aptamers Technology Market Share, By Applications, 2013 – 2018
Figure 8 Global Aptamers Market Share By Segments, 2013
Figure 9 Global Aptamers Market Share By Segments, 2018
Figure 10 Therapeutic Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 11 Therapeutic Aptamer Market By Region, 2013
Figure 12 Therapeutic Aptamer Market By Region, 2018
Figure 13 Diagnostics Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 14 Diagnostics Aptamers Market By Region, 2013
Figure 15 Diagnostics Aptamers Market By Region, 2018
Figure 16 Biosensor Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 17 Biosensor Aptamers Market By Region, 2013
Figure 18 Biosensor Aptamers Market By Region, 2018
Figure 19 Drug Discovery Aptamers Market, By Region, 2013 – 2018 ($Million)
Figure 20 Drug Discovery Aptamers Market By Region, 2013 80
Figure 21 Drug Discovery Aptamers Market By Region, 2018 80
Figure 22 Aptamers Biomarker Discovery Market, By Region, 2013 – 2018 ($Million)
Figure 23 Aptamers Biomarker Discovery Market By Region, 2013
Figure 24 Aptamers Biomarker Discovery Market By Region, 2018
Figure 25 Aptamers Research Applications Market, By Region, 2013 – 2018 ($Million)
Figure 26 Aptamers Research Applications Market By Region, 2013
Figure 27 Aptamers Research Applications Market By Region, 2018
Figure 28 Global Aptamers Market, Nucleic Acid Aptamer, 2013 – 2018 ($Million)
Figure 29 Global Aptamers Market, Peptide Aptamer, 2013 – 2018 ($Million)
The global aptamers market is anticipated to reach $2.1 billion by 2018 growing at a CAGR of 49.24%. The aptamers market is divided by geography (North America, Europe, Asia-Pacific and Rest of the World), application segments (therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications) and aptamer type (Nucleic acid aptamers and Peptide aptamers). Further each application segment and the aptamer type is broken down by geography, with exhaustive revenue analysis for the entire forecast period. Of the above mentioned application segments, research applications is the largest revenue segment; however, biomarker discovery and diagnostics will be the fastest-growing segment.
The potential growth of the market is attributed to future diagnostics, drug discovery and research applications. The future approval of a few diagnostic tests specifically for infectious diseases and a couple of drugs in the market will greatly propel the market. The global market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis. The market will experience continuous improvements in aptamer synthesis and its applicability in drug discovery and routine research. The market is witnessing a trend toward development of personalized medicine and point-of-care diagnostic tests. Additionally, the demand for safe and cost-effective drugs for treatment of cancer (which can be fulfilled by aptamer therapeutics), will remarkably fuel market growth.
North America is a significant contributor to the market, followed by Europe, due to the presence of technology providers and better R&D facilities. The new markets that are expected to grow at a brisk pace are emerging economics such as China, India, Japan and other regions of Asia-Pacific and untapped markets of Europe due to their growing GDP, healthcare costs, and rising demand for safe and cost-effective diagnostics and therapeutics.
Key players in this market are AM Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.), Aptamer Sciences Inc. (South Korea), Aptamer Solutions Ltd (U.K.), Base Pair Biotechnologies (U.S.), Bioapter S.L. (Spain), Integrated Biotechnologies, Inc. (U.S.), NOXXON Pharma AG (Germany), OTC Biotech (U.S.), Regado Biosciences, Inc. (U.S.), Somalogic, Inc. (U.S.), and TriLink BioTechnologies, Inc. (U.S.).
- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc